1033517-38-2

Upstream product

• 1033517-35-9 (2R,4S,5R)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carbonyl 7,10-(di-3'',5''-dinitrobenzoyl)-10-deacetylbaccatin III 
• 1033517-43-9 (2R,4S,5R)-3-t-butoxycarbonyl-2-t-butyl-4-phenyl-1,3-oxazolidine-5-carbonyl 7,10-(di-3'',5''-dinitrobenzoyl)-10-deacetylbaccatin III 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1033517-40-6 (2R,4S,5R)-3-t-butoxycarbonyl-2-isopropyl-4-phenyl-1,3-oxazolidine-5-carbonyl 7,10-(di-3'',5''-dinitrobenzoyl)-10-deacetylbaccatin III 
• 1033962-62-7 13-[(2'R,4'S,5'R)-3-t-butoxycarbonyl-2'-(1'-naphthyl)-4-phenyl-1,3'-oxazolidine-5'-carbonyl]-7,10-(di-3,5-dinitrobenzoyl)-10-deacetylbaccatin III 

Downstream Products

• 114915-20-7 Docetaxel 

Relevant academic research and scientific papers

METHOD OF PREPARING TAXANE DERIVATIVES AND INTERMEDIATES USED THEREIN

The present invention relates to a novel method of preparing a taxane derivative having an anti-tumor and anti-leukemia activity, and intermediates used therein.

METHOD OF PREPARING DOCETAXEL AND INTERMEDIATES USED THEREIN

The present invention relates to a novel method for preparing docetaxel having anti-tumor and anti-leukemia activity, and intermediates used therein.

DOCETAXEL / MONO PROPYLENE GLYCOL CLATHRATE AND METHOD FOR THE PREPARATION THEREOF

The present invention relates to a docetaxel / mono propylene glycol clathrate of formula (I) and a method for preparing same. The inventive docetaxel / mono propylene glycol clathrate having a low 7-epimer content and high stability can be advantageously used as an ingredient for the development of a therapeutic agent having anti-tumor and anti-leukemia activities.

METHOD OF PREPARING TAXANE DERIVATIVES AND INTERMEDIATES USED THEREIN

The present invention relates to a novel method of preparing a taxane derivative having an anti-tumor and anti-leukemia activity, and intermediates used therein.